Cyberknife® robotic stereotactic radiotherapy: Technical aspects and recent developments;La radiothérapie stéréotaxique avec Cyberknife®: Aspects pratiques et développements technologiques récents

Bulletin du Cancer

Volumn 97, Issue 7, 2010, Pages 807-818

  Thariat, J ^a   Marcie S ^a   Marcy, P Y ^a   Trimaud, R ^a   Angellier, G ^a   Mammar, H ^a   Bondiau, P Y ^a   Gerard, J P ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Curative; Cyberknife ; Hypofractionation; Oligometastatic; Quality assurance; Quality of life; Stereotactic irradiation; Technical innovations; Whole body

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; COLLIMATOR; CYBERKNIFE; EARLY CANCER; HUMAN; METASTASIS; QUALITY CONTROL; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; REVIEW; ROBOTICS; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TREATMENT INDICATION;

EID: 77955652369     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1141     Document Type: Review

References (30)

1. Gibbs IC, Levendag PC, Fariselli L, Bondiau PY, Lartigau E, Loo BW Jr et al. Re: "The safety and efficacy of robotic image-guided radiosurgery system treatment for intra- and extracranial lesions: a systematic review of the literature" [Radiother Oncol 89 (2009) 245-53].
2. Radiother Oncol 2009; 93: 656-7.
3. Lacornerie T, Mirabel X, Lartigau E. The Cyberknife®: experience of centre Oscar-Lambret. Cancer Radiother 2009; 13: 391-8.
4. Thariat J, Li G, Angellier G, Marchal S, Palamini G, Rucka G, et al. Current indications and ongoing clinical trials with Cyberknife® stereotactic radiotherapy in France in 2009. Bull Cancer 2009; 96: 853-64.
5. Fenoglietto P, Aillères N, Lemanski C, Llacer C, Dubois J, Azria D. RapidArc® technology: first year of experience at the Montpellier Comprehensive Cancer Centre. Bull Cancer 2010.
6. Dejean C, Kantor G, Henriques de Figueiredo B, Lisbona A, Mahé M, Mervoyer A, et al. Helical tomotherapy: description and clinical applications. Bull Cancer 2010.
7. Taste H, Beckendorf V, Bernier V, Graff P, Marchesi V, Noel A, et al. Extracranial stereotactic radiotherapy avancer by robotic radiosurgery: preliminary experience of the center Alexis-Vautrin. Bull Cancer 2009; 96: 865-74.
8. Bondiau PY, Benezery K, Beckendorf V, Peiffert D, Gerard JP, Mirabel X, et al. Cyberknife® robotic stereotactic radiotherapy: technical aspects and medical indications. Cancer Radiother 2007; 11: 338-44.
9. Wilcox EE, Daskalov GM, Lincoln H, Shumway RC, Kaplan BM, Colasanto JM. Comparison of planned dose distributions calculated by Monte-Carlo and Ray-Trace algorithms for the treatment of lung tumors with Cyberknife®: a preliminary study in 33 patients. Int J Radiat Oncol Biol Phys 2009.
10. Saliou MG, Giraud P, Simon L, Fournier-Bidoz N, Fourquet A, Dendale R, et al. Radiotherapy for breast cancer: respiratory and set-up uncertainties. Cancer Radiother 2005; 9: 414-21.
11. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects. Med Phys 1983; 10: 410-5.
12. Chuang CF, Larson DA, Zytkovicz A, Smith V, Petti PL. Peripheral dose measurement for Cyberknife® radiosurgery with upgraded linac shielding. Med Phys 2008; 35: 1494-6.
13. Poll JJ, Hoogeman MS, Prevost JB, Nuyttens JJ, Levendag PC, Heijmen BJ. Reducing monitor units for robotic radiosurgery by optimized use of multiple collimators. Med Phys 2008; 35: 2294-9.
14. Kawachi T, Saitoh H, Inoue M, Katayose T, Myojoyama A, Hatano K. Reference dosimetry condition and beam quality correction factor for Cyberknife® beam. Med Phys 2008; 35: 4591-8.
15. Thariat J, Castelli J, Chanalet S, Marcie S, Mammar H, Bondiau PY. Cyberknife® stereotactic radiotherapy for spinal tumors: value of computed tomographic myelography in spinal cord delineation. Neurosurgery 2009; 64 (2 Suppl): A60-A66.
16. Robar J, Riccio S, Martin M. Tumor dose enhancement using modified megavoltage photon beams and contrast media. Phys Med Biol 2002; 47: 2433-49.
17. Castelli J, Thariat J, Benezery K, Padovani B, Ducreux D, Venissac N, et al. Feasibility and efficacy of Cyberknife® radiotherapy for lung cancer: early results. Cancer Radiother 2008; 12: 793-9.
18. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2010; 7: 44-54.
19. Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 2004; 60: 1241-56.
20. Timmerman R, Bastasch M, Saha D, Abdulrahman R, Hittson W, Story M. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2007; 40: 352-65.
21. Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007; 25: 947-52. (Pubitemid 350002860)
22. Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008; 70: 847-52. (Pubitemid 351199730)
23. Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009; 114: 589-95.
24. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109-22.
25. Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys 1982; 8: 1761-9.
26. Milano MT, Zhang H, Metcalfe SK, Muhs AG, Okunieff P. Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat 2009; 115: 601-8.
27. Sahgal A, Ames C, Chou D, Ma L, Huang K, Xu W, et al. Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys 2009; 74: 723-31.
28. Balermpas P, Hambek M, Seitz O, Rodel C, Weiss C. Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck. Strahlenther Onkol 2009; 185: 775-81.
29. Levendag P. Introduction in contouring in head and neck. Elsevier, 2009. (Contouring in head and neck).
30. Bondiau PY, Bahadoran P, Lallement M, Birtwisle-Peyrottes I, Chapellier C, Chamorey E, et al. Robotic stereotactic radioablation concomitant with neoadjuvant chemotherapy for breast tumors. Int J Radiat Oncol Biol Phys 2009; 75: 1041-7.